Spot on. Credit has to be given to BLT's management. Nothing further to add"
Shoo BLT's management didn't have to lift a finger to acquire Tacere , she was always going to revert back to its original owner on the grounds Tacere wasn't able to take the program forward after Pfizer canned the project.The Hepc tt-033 has always belong to Benitec but was licensed out to Tacere for a fee I think back then (2005-2006)Tacere paid $6 million for it. Honestly to this day I cant think of one thing management has done that's added value to the company. Wait a second I think they did take out an add space in a qantas in flight magazine, which would have help passengers go to sleep on their long journey.
BLT Price at posting:
$2.09 Sentiment: Hold Disclosure: Held